Patients with well-documented chronic hepatitis C are being evaluated to determine the long-term natural history of this common form of chronic liver disease. A cohort of such patients are available to evaluate experimental therapies. Previous studies have shown that alpha interferon therapy has a short-term beneficial effect in approximately 50% of sustained in approximately 20% after stopping interferon. A randomized, placebo-controlled trial of ribavirin is currently underway. So far, 32 of 58 patients have completed the first year of the study. Prolonged ribavirin administration was associated with significant improvement in serum aminotransferase activities and in hepatic lobular necrosis despite unchanged serum levels of HCV RNA.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Promrat, Kittichai; Lutchman, Glen; Uwaifo, Gabriel I et al. (2004) A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39:188-96
Rahman, Fareed; Heller, Theo; Sobao, Yuji et al. (2004) Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology 40:87-97
Meyers, Catherine M; Seeff, Leonard B; Stehman-Breen, Catherine O et al. (2003) Hepatitis C and renal disease: an update. Am J Kidney Dis 42:631-57
Lutchman, Glen; Hoofnagle, Jay H (2003) Viral kinetics in hepatitis C. Hepatology 37:1257-9
Seeff, Leonard B; Hoofnagle, Jay H (2003) Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002. Clin Liver Dis 7:261-87
Hoofnagle, Jay H; Ghany, Marc G; Kleiner, David E et al. (2003) Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin. Hepatology 38:66-74
Promrat, Kittichai; McDermott, David H; Gonzalez, Carlos M et al. (2003) Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 124:352-60
Liang, T J; Rehermann, B; Seeff, L B et al. (2000) Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132:296-305
Reid, A E; Koziel, M J; Aiza, I et al. (1999) Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States. Am J Gastroenterol 94:1619-26
Munoz, S J; Alter, H J; Nakatsuji, Y et al. (1999) The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology. Blood 94:1460-4